Triple-Negative Breast Cancer (TNBC) Completed Phase 2 Trials for Cisplatin (DB00515)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01091454Brostallicin and Cisplatin in Treating Patients With Metastatic Breast CancerTreatment